Tag Archives: Gleevec

March, 2016

• 28 March

  New Hope for a Type 2 Diabetes Cure

  

  The cancer treatment drug Imatinib, otherwise known as Gleevec is approved to treat various forms of cancer, mostly notably chronic myeloid leukemia (CML). However, researchers have stumbled onto another possible use for it, curing type 2 diabetes. The team–made up of scientists from the Scripps Research Institute in United States, …

  Share

  • Facebook
  • Twitter
  • LinkedIn

December, 2015

• 4 December

  FDA Approves Sun Pharma’s Generic Gleevec

  

  Mumbai, December 04, 2015: Sun Pharmaceutical Industries Ltd. (Reuters: SUN.BO, Bloomberg: SUNP IN, NSE: SUNPHARMA, BSE: 524715, Sun Pharma) today announced that one of its subsidiaries has received final approval from US FDA for its Abbreviated New Drug Application (ANDA) for generic version of Gleevec®, Imatinib Mesylate tablets 100mg and …

  Share

  • Facebook
  • Twitter
  • LinkedIn